Shanghai implements the "Long-term Prescription Management Norms (Trial)"

District Health Commissions, Medical Insurance Bureaus, Shenkang Hospital Development Center, relevant universities, The China Welfare Association, the Shanghai Municipal Health Commission Supervision Institute, and municipal medical institutions: In order to standardize long-term prescription management, promote hierarchical diagnosis and treatment, ensure medical quality and medical safety, and meet the long-term drug needs of patients with chronic diseases, national health and health The General Office of the CPC Committee and the Office of the National Medical Security Bureau have formulated the "Notice on Printing and Distributing Long-term Prescription Management Specifications (Trial)" (National Health Office Medical Development [2021] No.
17) (hereinafter referred to as the "Norms"), please download them yourself in the "Medical Administration and Medical Management" column of the Website of the National Health Commission), and now forward it to you, please comply with the implementation, and combine the actual conditions of the city, put forward the following work requirements: First, improve ideological understanding, strengthen organizational management All district health commissions, medical entities and medical institutions should attach great importance to the "Norms" Fully understand the importance of the Code to standardize prescription management and promote graded diagnosis and treatment; It is necessary to guide and urge medical personnel, medical institution managers and health administrative personnel to seriously study, accurately understand and master the requirements of the "Norms", ensure medical quality and medical safety, and meet the long-term medication needs of patients with chronic diseases
.
Medical institutions shall perform the main responsibility of the long-term prescription management of the institution, establish and improve the long-term prescription management system of the institution, strengthen the allocation of long-term prescription drugs, and ensure that the long-term medication of patients is accessible and stable
.
Medical institutions shall periodically carry out reasonableness evaluation of long-term prescriptions, and continue to provide the level
of rational use of long-term prescriptions.
The Municipal Health Commission is responsible for the supervision and management of long-term prescriptions of medical institutions in the city, and the district health commissions are responsible for the supervision and management of
long-term prescriptions of medical institutions within their jurisdiction.
Second, clear applicable population, disease types and drug scope Long-term prescription is suitable for patients with chronic diseases
with clear clinical diagnosis, stable medication regimen, good compliance, stable disease control, and long-term drug treatment.
Commonly used medicines for the treatment of chronic diseases can be used for long-term prescriptions
.
Toxic drugs for medical use, radioactive drugs, precursor drugs, narcotic drugs, psychotropic substances of the first and second categories, antimicrobial drugs (except drugs for the treatment of chronic bacterial fungal infectious diseases such as tuberculosis), and drugs with special requirements for storage conditions shall not be used for long-term prescriptions
.
Medical institutions should actively play the role of the Pharmaceutical Affairs Management and Pharmacotherapeutics Committee, and according to the diagnosis and treatment norms, combined with the characteristics of disease treatment in the institution, formulate the long-term prescription applicable diseases and the scope of long-term prescription drugs of the institution, and optimize and adjust
them every year.
Encourage the preferential selection of national essential drugs, selected drugs in centralized procurement by state organizations, and drugs
in the national medical insurance list.
Third, strengthen the management of medical insurance, to ensure the rights and interests of insured personnel Designated medical institutions should effectively protect the reasonable needs of long-term prescriptions of insured personnel in accordance with the requirements of the "Norms" and clinical practices, and must not restrict the rational use
of long-term prescriptions on the grounds of total medical insurance budget management.
Medical insurance departments at all levels should fully consider the impact of long-term prescription factors in designated medical institutions, and do a good job in the overall balance
of the total medical insurance budget.
It is necessary to strengthen intelligent monitoring and intelligent auditing to ensure the rational use of drugs and protect the rights and interests of insured persons
.
Notice is hereby given
.
Shanghai Municipal Health Commission Shanghai Municipal Medical Security Bureau August 19, 2022 Health I, improve ideological understanding, strengthen organizational management II, clarify the applicable population, disease types and drug scope drug disease procurement III, strengthen medical insurance management, and ensure the rights and interests of insured persons